perindopril has been researched along with Cerebrovascular Disorders in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 15 (50.00) | 18.2507 |
2000's | 13 (43.33) | 29.6817 |
2010's | 2 (6.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harada, M; Inoue, N | 1 |
Anderson, C; Bousser, MG; Chalmers, J; Coskun, O; Dufouil, C; Godin, O; MacMahon, S; Mazoyer, B; Tzourio, C; Tzourio-Mazoyer, N | 1 |
Anderson, C; Arima, H; Chalmers, J; Liu, L; Macmahon, S; Neal, B; Omae, T; Rodgers, A; Tzourio, C; Woodward, M | 1 |
Gapon, LI | 1 |
Anderson, C; Chalmers, J; Chapman, N; MacMahon, S; Neal, B; Tzourio, C; Woodward, M | 1 |
Anderson, C; Chalmers, J; Chapman, N; Davis, S; Fransen, M; MacMahon, S; Neal, B; Sega, R; Terent, A; Tzourio, C; Woodward, M | 1 |
Anderson, C; Bousser, MG; Chalmers, J; Chapman, N; Colman, S; Davis, S; Donnan, G; Huxley, R; MacMahon, S; Neal, B; Warlow, C; Woodward, M | 1 |
Algert, C; Bath, P; Chapman, N; Neal, B | 1 |
Campbell, DJ; Chalmers, JP; Colman, SA; Jenkins, AJ; Kemp, BE; MacMahon, SW; Neal, BC; Patel, A; Woodward, M | 3 |
Campo, G; Ceconi, C; Ferrari, R; Gardini, E; Notarstefano, P; Pasanisi, G | 1 |
Arima, H; Cass, A; Chalmers, J; Gallagher, M; Jardine, M; Macmahon, S; Neal, B; Ninomiya, T; Perkovic, V | 1 |
Gohlke, P; Unger, T | 1 |
Bartenbach, S; Gohlke, P; Kuwer, I; Schnell, A; Unger, T | 1 |
Lee, RM; Smeda, JS; Wang, H | 3 |
Head, GA; Minami, N | 1 |
Arribas, SM; Daly, CJ; Dominiczak, AF; Gordon, JF; McGrath, JC | 1 |
Anderson, C; Chalmers, J; MacMahon, S; Neal, B; Rodgers, A | 1 |
Dyker, AG; Lees, KR | 1 |
Dyker, AG; Grosset, DG; Lees, K | 1 |
Cleland, JG | 1 |
Delaney, KH; Kwiecien, JM; Lee, RM; Smeda, JS; Wang, H | 1 |
Chalmers, J | 1 |
2 review(s) available for perindopril and Cerebrovascular Disorders
Article | Year |
---|---|
Specific properties and effect of perindopril in controlling the renin-angiotensin system.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cerebrovascular Disorders; Coronary Artery Disease; Heart Failure; Humans; Hypertension; Perindopril; Renin-Angiotensin System | 2005 |
Blood pressure control after acute stroke.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cerebrovascular Circulation; Cerebrovascular Disorders; Humans; Indoles; Perindopril | 1996 |
14 trial(s) available for perindopril and Cerebrovascular Disorders
Article | Year |
---|---|
Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Brain; Cerebrovascular Disorders; Cognition Disorders; Dementia; Disease Progression; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Perindopril; Predictive Value of Tests; Recurrence; Stroke | 2009 |
Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial.
Topics: Aged; Antihypertensive Agents; Asian People; Blood Pressure; Cerebrovascular Disorders; Coronary Disease; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Perindopril; Risk Factors; Stroke; Vascular Diseases; White People | 2010 |
Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cerebrovascular Disorders; Coronary Disease; Death, Sudden, Cardiac; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Perindopril; Risk Factors; Treatment Outcome | 2003 |
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; Cognition; Cognition Disorders; Dementia; Diuretics; Double-Blind Method; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Risk; Treatment Outcome | 2003 |
Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.
Topics: Activities of Daily Living; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; Dependency, Psychological; Diuretics; Double-Blind Method; Female; Follow-Up Studies; Humans; Indapamide; Ischemic Attack, Transient; Male; Middle Aged; Odds Ratio; Outpatients; Perindopril; Risk Assessment; Secondary Prevention; Stroke; Time; Treatment Outcome | 2003 |
Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Brain Ischemia; Cerebral Hemorrhage; Cerebrovascular Disorders; Diuretics; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Risk; Secondary Prevention; Stroke; Treatment Outcome | 2004 |
Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in individuals with cerebrovascular disease.
Topics: Aged; Antihypertensive Agents; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Perindopril; Risk Factors | 2007 |
Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Blood Pressure; Case-Control Studies; Cerebral Hemorrhage; Cerebrovascular Disorders; Female; Humans; Hypertension; Lipoproteins, LDL; Male; Middle Aged; Odds Ratio; Particle Size; Perindopril; Prognosis; Risk Assessment; Risk Factors; Secondary Prevention; Systole | 2007 |
Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study.
Topics: Aged; Antihypertensive Agents; Cardiovascular Diseases; Cerebrovascular Disorders; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Perindopril; Risk Factors | 2007 |
Blood pressure lowering in patients with cerebrovascular disease: results of the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) pilot phase.
Topics: Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; Female; Humans; Indoles; Male; Perindopril; Pilot Projects; Retrospective Studies | 1996 |
PROGRESS--perindopril protection against recurrent stroke study: status in July 1996. PROGRESS Management Committee.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cerebrovascular Disorders; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Perindopril; Recurrence | 1996 |
Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Brain Ischemia; Cerebrovascular Circulation; Cerebrovascular Disorders; Double-Blind Method; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Placebos; Ultrasonography | 1997 |
PROGRESS: Perindopril pROtection aGainst REcurrent Stroke Study: status in March 1997. PROGRESS Management Committee.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cerebrovascular Disorders; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Indoles; Male; Middle Aged; Perindopril; Prognosis; Recurrence; Survival Rate; Treatment Outcome; World Health Organization | 1998 |
PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cerebrovascular Disorders; Diuretics; Double-Blind Method; Female; Humans; Hypertension; Indapamide; Ischemic Attack, Transient; Male; Middle Aged; Perindopril; Risk Factors; Secondary Prevention; Stroke | 1999 |
14 other study(ies) available for perindopril and Cerebrovascular Disorders
Article | Year |
---|---|
Effect of perindopril on vasoreactivity in patients with hypertensive chronic cerebrovascular disease. A comparative analysis of different brain structures.
Topics: Acetazolamide; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Diabetes Complications; Diuretics; Female; Humans; Hypertension; Intracranial Hemorrhages; Magnetic Resonance Imaging; Male; Middle Aged; Perindopril; Thalamic Diseases; Tomography, X-Ray Computed | 2008 |
[Angiotensin converting enzyme inhibitor perindopril in the treatment of patients with arterial hypertension and renal failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cerebrovascular Disorders; Disease Progression; Drug Dosage Calculations; Humans; Hypertension, Renal; Kidney Function Tests; Monitoring, Physiologic; Perindopril; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2010 |
Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Australia; Blood Platelets; Cell Size; Cerebrovascular Disorders; China; Comorbidity; Coronary Disease; Diuretics; Female; Follow-Up Studies; Humans; Incidence; Ischemic Attack, Transient; Japan; Male; Middle Aged; Multicenter Studies as Topic; New Zealand; Perindopril; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Assessment; Secondary Prevention; Stroke; Sweden | 2004 |
Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; C-Reactive Protein; Case-Control Studies; Cerebrovascular Disorders; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Incidence; Ischemic Attack, Transient; Male; Middle Aged; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptide Fragments; Perindopril; Predictive Value of Tests; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Sensitivity and Specificity; Stroke | 2005 |
Chronic low-dose treatment with perindopril improves cardiac function in stroke-prone spontaneously hypertensive rats by potentiation of endogenous bradykinin.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Cerebrovascular Disorders; Cyclic GMP; Epoprostenol; Heart; Hypertension; Hypertrophy, Left Ventricular; Indoles; Myocardium; Perindopril; Rats; Rats, Inbred SHR; Ventricular Pressure | 1995 |
Effect of low-dose treatment with perindopril on cardiac function in stroke-prone spontaneously hypertensive rats: role of bradykinin.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Cerebrovascular Disorders; Coronary Circulation; Creatine Kinase; Cyclic GMP; Disease Models, Animal; Glycogen; Heart; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Indoles; L-Lactate Dehydrogenase; Myocardium; Perindopril; Rats; Rats, Inbred SHR | 1994 |
Effects of perindopril on hypertension and stroke prevention in experimental animals.
Topics: Analysis of Variance; Animals; Antihypertensive Agents; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Hypertension; Indoles; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1994 |
Relationship between cardiovascular hypertrophy and cardiac baroreflex function in spontaneously hypertensive and stroke-prone rats.
Topics: Animals; Blood Pressure; Blood Vessels; Body Weight; Cardiomegaly; Cerebrovascular Disorders; Drinking; Heart Rate; Hypertension; Hypertrophy; Indoles; Male; Perindopril; Pressoreceptors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reflex | 1993 |
Confocal microscopic characterization of a lesion in a cerebral vessel of the stroke-prone spontaneously hypertensive rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Basilar Artery; Blood Pressure; Cerebrovascular Disorders; Coloring Agents; Female; Fluoresceins; Fluorescent Dyes; Image Processing, Computer-Assisted; Indoles; Male; Microscopy, Confocal; Muscle, Smooth, Vascular; Perindopril; Potassium Chloride; Propidium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Serotonin; Vasoconstrictor Agents | 1996 |
Perindopril treatment in the prevention of stroke in experimental animals.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cerebral Arteries; Cerebrovascular Disorders; Heart Rate; Hypertension; Indoles; Male; Muscle, Smooth, Vascular; Perindopril; Rats; Rats, Inbred SHR | 1996 |
Adverse event with first-dose perindopril in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cerebrovascular Disorders; Heart Failure; Humans; Hypotension; Indoles; Perindopril | 1997 |
Prevention of stroke with perindopril treatment in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Brain; Cerebral Cortex; Cerebrovascular Disorders; Heart Rate; Hypertension; Indoles; Kidney; Kidney Diseases; Male; Perindopril; Prospective Studies; Rats; Rats, Inbred SHR; Survival Rate; Time Factors | 1997 |
Prevention of stroke and preservation of the functions of cerebral arteries by treatment with perindopril in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cerebral Arteries; Cerebrovascular Disorders; Hypertrophy; Indoles; Male; Muscle, Smooth, Vascular; Perindopril; Pressure; Rats; Rats, Inbred SHR; Stress, Mechanical; Time Factors; Vasoconstriction | 1998 |
Blood pressure burden: vascular changes and cerebrovascular complications.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; Humans; Hypertension; Perindopril; Stroke | 2000 |